Neurocrine Chief Financial Officer Matt Abernethy was recently featured in @CNBC Cures, where he shared the personal journey that helped bring him to Neurocrine.

As a father of a son living with classic congenital adrenal hyperplasia, a rare endocrine disorder, Matt understands firsthand the challenges families face and the hope they hold for new treatment options. His story highlights the powerful connection between personal experience, purpose-driven leadership and the pursuit of scientific innovation.

We are grateful for leaders like Matt who share their experiences and remind us why advancing science for patients and families matters.

https://link.cnbc.com/public/46415659